Vanda Pharmaceuticals Inc. Stock News

Vanda (VNDA) delivered earnings and revenue surprises of 0.00% and -4.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

WASHINGTON, July 28, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the second quarter ended June 30, 2021. "Vanda had an

WASHINGTON, July 21, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2021 on Wednesday, July 28, 2021, after the

Vanda (VNDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th

Retail investors bought more stocks on Friday than at any other time on record, taking advantage of a sharp drop in share prices, analysts at Vanda Research said on Wednesday.

Vanda Pharmaceuticals is enjoying steady sales growth from its two approved medicines, Hetlioz and Fanapt.Despite increasing revenues, Vanda is pushing aggressively for additional growth through label

WASHINGTON, May 12, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the following investor conferences: Bank of Ameri

With the trading day about halfway over, the markets were getting crushed. The Nasdaq was again facing the worst of this, with the index down about 2%.

Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q1 2021 Results - Earnings Call Transcript

Vanda (VNDA) delivered earnings and revenue surprises of 7.14% and 166.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

WASHINGTON, May 5, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2021. "Despite season

WASHINGTON, April 20, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2021 on Wednesday, May 5, 2021, after the ma

DENVER--(BUSINESS WIRE)--Shuman, Glenn & Stecker Investigates Vanda Pharmaceuticals, Inc. (Nasdaq: VNDA)

SAN DIEGO & WASHINGTON--(BUSINESS WIRE)---- $VNDA #ClassAction--Shareholder rights law firm Robbins LLP announces that Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) may face damages caused by a pending se

Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2020 Results - Earnings Call Transcript